Motoneuron-disease-like disorder after ganglioside therapy
- 3 August 1991
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 338 (8762), 314-315
- https://doi.org/10.1016/0140-6736(91)90453-v
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 8 references indexed in Scilit:
- Acute axonal polyneuropathy associated with anti‐GM 1 antibodies following Campylobacter enteritisNeurology, 1990
- Anti‐GM 1 IgM antibodies in motor neuron disease and neuropathyNeurology, 1990
- Critical review of gangliosides and thyrotropin-releasing hormone in peripheral neuromuscular diseasesMuscle & Nerve, 1990
- The spectrum of neurologic disease associated with anti‐GM 1 antibodiesNeurology, 1990
- Lower motor neuron disease in a patient with auto‐antibodies against Gal(β 1‐3)GalNAc in gangliosides GM 1 and GD 1bNeurology, 1990
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990
- A treatable multifocal motor neuropathy with antibodies to GM1 gangliosideAnnals of Neurology, 1988
- Monoclonal IgM with unique specificity to gangliosides GM 1 and GD 1b and to lacto‐ N ‐tetraose associated with human motor neuron diseaseNeurology, 1988